Rubicon Research cash flow

Latest FY26
Cash from operations
₹205cr 
Capital spending
₹229cr 
Free cash flow
−₹24.1cr 
Cash from financing
₹283cr 
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026
Adjustments to reconcile profit — non-cash items
—45.3
—42.2
—−7.1
—−0.0
—16.7
—9.4
—−0.0
—0.2
—1.0
Changes in working capital
—−207
—−180
—5.9
—−0.1
—136
—13.5
—12.0
—105
Cash from operating activities
371321
—−7.0
—314
—109
—205
Cash from investing activities
—229
—0.2
—0.0
—21.0
—148
—0.0
—5.4
—−17.1
—−410
Cash from financing activities
—476
—7.2
—125
—277
—10.6
—36.5
—0.3
—283
—78.4
—2.3
—80.7
Reference items
450400
23.3%22.8%
−24.1−24.1
−₹1.46−₹1.46
—0.83×
—109
—36.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RUBICON₹1,559.30

Rubicon Research Ltd.

· Pharma & Health
₹ CrorePeersSHILPAMEDSPARCSTARSUPRIYAPARKHOSPSTHYROCAREMETROPOLISMARKSANSMcap ₹25,742 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation45.3—
+ Finance Costs42.2—
+ Interest Income-7.1—
+ Dividend Income-0.0—
+ Fair Value (Gains) / Losses16.7—
+ Share-based Payments9.4—
+ Unrealised FX (Gain) / Loss-0.0—
+ Other Non-cash Items0.2—
+ Other Reconciling Items1.0—
Changes in Working Capital
+ Inventories-207.4—
+ Trade Receivables — Current-179.7—
+ Other Financial Assets — Current5.9—
+ Other Current Assets-0.1—
+ Trade Payables — Current136.0—
+ Other Financial Liabilities — Current13.5—
+ Other Current Liabilities12.0—
+ Provisions — Current105.2—
Cash from Operating Activities
Profit Before Tax (per I/S)320.5371.4
+ Total Adjustments (incl. Working Capital)-7.0—
Cash from Operations (pre-tax)313.6—
+ Income Taxes Paid108.5—
Cash from Operating Activities205.0—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)229.2—
+ Disp of Fixed Assets0.2—
+ Disp of Other Long-term Assets0.0—
+ Purchase of Investments (Equity / Debt)21.0—
+ Loans & Advances Made148.2—
+ Dividends Received — Investing0.0—
+ Interest Received — Investing5.4—
+ Other Inflows / (Outflows) — Investing-17.1—
Cash from Investing Activities-409.7—
Cash from Financing Activities
+ Proceeds from Issue of Shares476.0—
+ Proceeds from Exercise of Stock Options7.2—
+ Proceeds from Borrowings124.7—
+ Repayment of Borrowings277.4—
+ Payment of Lease Liabilities10.6—
+ Interest Paid36.5—
+ Dividends Paid0.3—
Cash from Financing Activities283.1—
Net Changes in Cash (pre-FX)78.4—
+ Effect of FX Rate Changes on Cash2.3—
Net Changes in Cash80.7—
Reference Items
EBITDA400.2450.2
EBITDA Margin %22.8223.26
Free Cash Flow (CFO − Capex)-24.1-24.1
Free Cash Flow per Basic Share-1.46-1.46
Cash Flow to Net Income0.83—
Cash Paid for Taxes108.5—
Cash Paid for Interest36.5—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.